Literature DB >> 15329608

Reversal of minimum alveolar concentrations of volatile anesthetics by chromosomal substitution.

Thomas A Stekiel1, Stephen J Contney, Zeljko J Bosnjak, John P Kampine, Richard J Roman, William J Stekiel.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15329608     DOI: 10.1097/00000542-200409000-00032

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  5 in total

1.  Enhancement of resting-state fcMRI networks by prior sensory stimulation.

Authors:  Chenxuan Li; Zhixin Li; B Douglas Ward; Melinda R Dwinell; Julian H Lombard; Anthony G Hudetz; Christopher P Pawela
Journal:  Brain Connect       Date:  2014-11

2.  Pharmacogenomic strain differences in cardiovascular sensitivity to propofol.

Authors:  Thomas A Stekiel; Stephen J Contney; Richard J Roman; Craig A Weber; Anna Stadnicka; Zeljko J Bosnjak; Andrew S Greene; Carol Moreno
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

3.  Strain differences in cortical electroencephalogram associated with isoflurane-induced loss of consciousness.

Authors:  J Bruce McCallum; Siveshigan Pillay; Jeannette A Vizuete; Gary Mouradian; Anthony G Hudetz; Thomas A Stekiel
Journal:  Anesthesiology       Date:  2013-02       Impact factor: 7.892

4.  Differences in cardiovascular sensitivity to propofol in a chromosome substitution rat model.

Authors:  Thomas A Stekiel; Craig A Weber; Stephen J Contney; Zeljko J Bosnjak
Journal:  Croat Med J       Date:  2007-06       Impact factor: 1.351

5.  Mechanism of differential cardiovascular response to propofol in Dahl salt-sensitive, Brown Norway, and chromosome 13-substituted consomic rat strains: role of large conductance Ca2+ and voltage-activated potassium channels.

Authors:  Anna Stadnicka; Stephen J Contney; Carol Moreno; Dorothee Weihrauch; Zeljko J Bosnjak; Richard J Roman; Thomas A Stekiel
Journal:  J Pharmacol Exp Ther       Date:  2009-06-18       Impact factor: 4.030

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.